Symbol
VYNE Therapeutics Inc.
Full name of the company.
MEDICAL-DRUGS
Industry name
DRUGS
Major industry name
Medical
Sector name
$1.56
Current price of the stock
$100K
Trading volume of the stock
$66.4M
Market capitalization of the company
Micro Cap
Category of market capitalization
-
Long-term growth mean estimate
5.00
Mean analyst rating
376.73%
Potential price appreciation based on analyst price targets
-
Percentage difference of EPS surprise
-
Dividend change over 1 year
$0.00
Shows the amount of dividend paid
-
Total debt to total equity ratio
5.81
Current ratio
100.00%
Gross profit margin
-10819.01%
Operating profit margin
-10819.01%
Earnings before interest and taxes (EBIT) margin
-
Earnings before interest, taxes, depreciation, and amortization (EBITDA) margin
-10047.11%
Pretax profit margin
-10047.11%
Net profit margin
-19.13%
Measures profitability relative to shareholders' equity
-19.13%
ROE excluding intangible assets
-15.95%
Measures profitability relative to total assets
-19.13%
Measures profitability relative to invested capital
0.00
Asset turnover ratio
-
Inventory turnover ratio
-
Receivables turnover ratio
-
Average number of days it takes to collect receivables
0.46
Measures valuation relative to earnings
-
P/E based on future earnings estimates
134.76
Measures valuation relative to sales
0.36
Measures valuation relative to book value
-0.43
Measures valuation relative to operating cash flow
-0.43
Measures valuation relative to free cash flow
5
Indicates company's M&A activity
© 2022 - 2025 QuantStrategy.io, Arizet Labs, LLC
